Twenty-four months follow-up of chronic central serous chorioretinopathy patients after treatment with oral eplerenone or half-dose photodynamic therapy, and crossover treatment: SPECTRA trial report No. 4

被引：0
|
作者：
van Rijssen, Th. J. [1 ]
Feenstra, H. M. A. [1 ]
van Dijk, E. H. C. [1 ]
Tsonaka, R. [2 ]
Diederen, R. M. H. [3 ]
Hoyng, C. B. [4 ]
Schlingemann, R. O. [3 ]
Boon, C. J. F. [1 ,3 ]
机构：
[1] Leiden Univ, Med Ctr, Dept Ophthalmol, Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands
[3] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands
[4] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, Nijmegen, Netherlands
来源：
ACTA OPHTHALMOLOGICA | 2022年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：18 / 18
页数：1
相关论文
共 48 条
  • [1] Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment. SPECTRA trial report No. 4
    Feenstra, H. M. A.
    van Rijssen, T. J.
    El Mansori, I.
    Diederen, R. M. H.
    Hoyng, C. B.
    Schlingemann, R. O.
    van Dijk, E. H. C.
    Boon, C. J. F.
    ACTA OPHTHALMOLOGICA, 2023, 101 : 25 - 25
  • [2] Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3
    Feenstra, Helena M. A.
    van Dijk, Elon H. C.
    van Rijssen, Thomas J.
    Tsonaka, Roula
    Diederen, Roselie M. H.
    Hoyng, Carel B.
    Schlingemann, Reinier O.
    Boon, Camiel J. F.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 261 (03) : 659 - 668
  • [3] Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3
    Feenstra, Helena
    van Rijssen, Thomas Jurian
    Diederen, Roselie
    Hoyng, Carel
    Schlingemann, Reinier
    van Dijk, Elon
    Boon, Camiel J. F.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [4] Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3
    Helena M. A. Feenstra
    Elon H. C. van Dijk
    Thomas J. van Rijssen
    Roula Tsonaka
    Roselie M. H. Diederen
    Carel B. Hoyng
    Reinier O. Schlingemann
    Camiel J. F. Boon
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2023, 261 : 659 - 668
  • [5] Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment. SPECTRA trial report No. 3
    Feenstra, H. M. A.
    van Rijssen, T. J.
    Diederen, R. M. H.
    Hoyng, C. B.
    Schlingemann, R. O.
    van Dijk, E. H. C.
    Boon, C. J. F.
    ACTA OPHTHALMOLOGICA, 2021, 99 : 35 - 35
  • [6] Crossover to Half-dose Photodynamic Therapy or Eplerenone Treatment after Failure of Primary Treatment in Patients with Chronic Central Serous Chorioretinopathy: SPECTRA Trial Report No. 2
    Boon, C. J. F.
    Feenstra, H. M. A.
    van Rijssen, T. J.
    Diederen, R. M. H.
    Hoyng, C. B.
    Schlingemann, R. O.
    van Dijk, E. H. C.
    ACTA OPHTHALMOLOGICA, 2021, 99 : 35 - 35
  • [7] Crossover to Half-Dose Photodynamic Therapy or Eplerenone in Chronic Central Serous Chorioretinopathy Patients
    Feenstra, Helena M. A.
    van Dijk, Elon H. C.
    van Rijssen, Thomas J.
    Tsonaka, Roula
    Diederen, Roselie M. H.
    Schlingemann, Reinier O.
    Hoyng, Carel B.
    Boon, Camiel J. F.
    OPHTHALMOLOGY RETINA, 2022, 6 (10): : 930 - 938
  • [8] Half-Dose Photodynamic Therapy Versus Eplerenone in Chronic Central Serous Chorioretinopathy (SPECTRA): A Randomized Controlled Trial
    van Rijssen, Thomas J.
    van Dijk, Elon H. C.
    Tsonaka, Roula
    Feenstra, Helena M. A.
    Dijkman, Greet
    Peters, Petrus J. H.
    Diederen, Roselie M. H.
    Hoyng, Carel B.
    Schlingemann, Reinier O.
    Boon, Camiel J. F.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2022, 233 : 101 - 110
  • [9] Microstructural changes after half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy
    Esen, Ebru
    Sizmaz, Selcuk
    Demircan, Nihal
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2021, 35
  • [10] Comparison of half-dose photodynamic therapy and 689 nm laser treatment in eyes with chronic central serous chorioretinopathy
    Andrea Russo
    Raffaele Turano
    Francesco Morescalchi
    Elena Gambicorti
    Anna Cancarini
    Sarah Duse
    Ciro Costagliola
    Francesco Semeraro
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2017, 255 : 1141 - 1148
12345